Galapagos ( ($GLPG) ) just unveiled an update. On November 3, 2025, Galapagos NV announced that it will present new data for its CAR T-cell ...

In late October 2025, Ardelyx presented new real-world and clinical data for its IBSRELA (tenapanor) therapy at the American College of Gastroenterology’s Annual Meeting, showing high patient ...

A man taking warfarin presents with blood-stained saliva and swelling that rapidly progresses to airway obstruction, ...

Highlights New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose levelPositive data from ATH434-202 open-label ...

Prompt, intensive blood pressure lowering within days of a TIA or minor stroke cuts recurrent stroke rates, results of a ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

Poland and other countries across Europe that found economic success in an era of collaboration are now facing a crumbling of ...

But some Dividend Kings are better than others. Here's my favorite Dividend King to buy in November.

PHM continues to advance with diverse research impacting clinical care, quality improvement, and health equity. The top 10 ...

Guardant Health posts strong Q3 results and lifts outlook. See insights on GH stock's growth, financials, and what’s driving ...

It was essentially a miracle that I’m still alive,” says Emily, 33, a mother of two from Canada, in words carrying the weight ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...